CM
EWTX icon

Caption Management’s Edgewise Therapeutics EWTX Stock Holding History

Caption Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.72M Buy
150,000
+72,500
+94% +$2.09M 0.03% 550
2025
Q4 		$1.92M Buy
+77,500
New +$1.56M 0.01% 849
2025
Q2 		– Sell
-650,300
Closed -$14.3M – 1596
2025
Q1 		$14.3M Buy
650,300
+352,100
+118% +$9.24M 0.14% 134
2024
Q4 		$7.96M Sell
298,200
-522,000
-64% -$16.6M 0.08% 244
2024
Q3 		$21.9M Buy
+820,200
New +$16.3M 0.35% 60

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Caption Management's EWTX Position: Q1 2026 in Review

Caption Management opened a new position in Edgewise Therapeutics (EWTX) in Q1 2026: 38,675 shares worth $1.22M. The stake represents 0.01% of the portfolio and ranks #956 among its holdings. This is a return to the name: Caption Management previously reported a position in EWTX as recently as Q1 2025.

Caption Management first reported a position in EWTX in Q1 2025 and has held it in 2 quarters since. The position peaked at $4.5M in Q1 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Caption Management held 38,675 shares of Edgewise Therapeutics worth $1.22M as of Q1 2026.
  • Edgewise Therapeutics was a new Caption Management position in Q1 2026.
  • Edgewise Therapeutics made up 0.01% of Caption Management's portfolio in Q1 2026, its #956 holding.
  • Caption Management first reported a position in Edgewise Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • Caption Management's Edgewise Therapeutics position peaked at $4.5M in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.